Importation Of Us-labelled Rocuronium Bromide Injection Distributed By Avir Pharma Inc. Due To Shortage Of Canadian-labelled Rocuronium

Rocuronium Bromide Injection products labeled for the US market are being distributed in Canada by Avir Pharma Inc. due to a shortage of Canadian-labeled versions of this drug. This product is being recalled because it does not meet Canadian labeling and regulatory requirements. The affected product has been distributed across Canada.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2020-05-25

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/894856af-9824-4153-8ff7-2993797ec7c7